Former Bard executives sentenced for FDA evasion
This article was originally published in Clinica
Executive Summary
Three ex-executives of CR Bard have pleaded guilty to charges in US federal court that date back some eight years concerning Bard's Miniprofile, Probe B and Probe C cardiac catheters.